Marqués de Valdecilla University Hospital - Academic Profile

Publications

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo , Richard S. Finn , Shukui Qin +19 more

2018 The Lancet 5118 citations

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio , Catalina Amador , Ioannis Anagnostopoulos +80 more

Abstract We herein present an overview of the upcoming 5 th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. M...

2022 Leukemia 3136 citations

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Brian W. Kunkle , Benjamin Grenier‐Boley , Rebecca Sims +97 more

2019 Nature Genetics 2968 citations

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Thierry André , Kai‐Keen Shiu , Tae Won Kim +18 more

Pembrolizumab led to significantly longer progression-free survival than chemotherapy when received as first-line therapy for MSI-H-dMMR metastatic colorectal cancer, with fewer...

2020 New England Journal of Medicine 2637 citations

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

Chris Estes , Quentin M. Anstee , M. Arias +28 more

2018 Journal of Hepatology 1893 citations

Affiliated Researchers

Carlos López

Marqués de Valdecilla University Hospital

Fernando Rivera

Marqués de Valdecilla University Hospital

Institution Info

Type: healthcare
Country: ES
Publications: 5
Citations: 15,752

External Links

Identifiers

ROR: https://ror.org/01w4yqf75